FIELD: biotechnology.
SUBSTANCE: activity modulator, which is a remedy for modulation of activity of CD300b-dependent phagocytosis, and its use, a drug, and a method for the treatment or prevention of diseases mediated by this activity are presented.
EFFECT: activity modulator contains CD300a-binding substance and modulates CD300b-dependent phagocytosis signals in macrophages, which leads to the effective treatment of diseases.
8 cl, 8 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND AGENTS | 2005 |
|
RU2480770C2 |
| THERAPEUTIC AGENT FOR TREATING NERVOUS SYSTEM DISEASE | 2018 |
|
RU2825666C2 |
| PHARMACEUTICAL PREPARATION CONTAINING SUPERNATANT OF BLOOD MONONUCLEAR CELL CULTURE | 2009 |
|
RU2533253C2 |
| THERAPY FOR STIMULATION OF CELL GROWTH | 2010 |
|
RU2586302C2 |
| CELL-BASED THERAPY OF ISCHEMIC TISSUE | 2009 |
|
RU2535966C2 |
| USING 5?-ANDROSTANE-3(,5,6(-TRIOL FOR PREPARING NEUROPROTECTIVE DRUGS | 2011 |
|
RU2541093C2 |
| METHODS OF NEURAL DISORDER TREATMENT WITH USING HEMATOPOIETIC GROWTH FACTORS | 2003 |
|
RU2353385C2 |
| VERSIONS OF ERYTHROPOETINE | 2006 |
|
RU2430162C2 |
| BICYCLIC PYRIMIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS - ANTIOXIDANT PROGRAMME ACTIVATORS AND USING THEM AS CYTOPROTECTORS | 2014 |
|
RU2545758C1 |
| AGENT FOR PREVENTING PROGRESSION OF APOPTOTIC AND ARRESTING NECROTIC ALTERATIONS IN BODY TISSUE | 2005 |
|
RU2311180C2 |
